Cargando…

Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy

OBJECTIVES: To investigate the causes of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy. METHODS: The clinical data of 759 patients who underwent transperineal prostate biopsy from March 2021 to June 2021 at Nanjing DrumTower Hospital were retrospectively analyzed. Twenty-one...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fan, Zhang, Shun, Huang, Haifeng, Zhang, Qing, Zhang, Shengjie, Zhang, Shiwei, Guo, Hongqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074335/ https://www.ncbi.nlm.nih.gov/pubmed/35513861 http://dx.doi.org/10.1186/s12894-022-01021-8

Ejemplares similares

The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer
por: Zhang, Xin, et al.
Publicado: (2022)

Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy
por: Xu, Guang, et al.
Publicado: (2022)

Prostate Cancer Detection with mpMRI According to PI-RADS v2 Compared with Systematic MRI/TRUS-Fusion Biopsy: A Prospective Study
por: Sauck, Anja, et al.
Publicado: (2022)

Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy
por: Lazzeri, Massimo, et al.
Publicado: (2017)

Role of mpMRI of the prostate in screening for prostate cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2017)

Impact of operator expertise on transperineal free-hand mpMRI-fusion-targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicenter prospective learning curve
por: Calleris, Giorgio, et al.
Publicado: (2023)

Non-timely clinically applicable ADC ratio in prostate mpMRI: a comparison with fusion biopsy results
por: Falaschi, Zeno, et al.
Publicado: (2022)

Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate?
por: Rezaee, Michael E., et al.
Publicado: (2020)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
por: Nyk, Łukasz, et al.
Publicado: (2021)

Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Demirtaş, Abdullah, et al.
Publicado: (2020)

Pearls and pitfalls in diagnosing prostate cancer using multiparametric MRI (mpMRI)
por: Joshi, JJ, et al.
Publicado: (2015)

External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy
por: Pallauf, Maximilian, et al.
Publicado: (2022)

MRI‐TRUS registration methodology for TRUS‐guided HDR prostate brachytherapy
por: McGeachy, Philip, et al.
Publicado: (2021)

How to Improve TRUS-Guided Target Biopsy following Prostate MRI
por: Park, Byung Kwan
Publicado: (2021)

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
por: Campistol, Miriam, et al.
Publicado: (2022)

Comparison of (68)Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer
por: Zhang, Qing, et al.
Publicado: (2017)

The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
por: Benelli, Andrea, et al.
Publicado: (2020)

Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends
por: Bardis, Michelle D., et al.
Publicado: (2020)

bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
por: Pan, Yongsheng, et al.
Publicado: (2023)

Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy
por: Wei, G., et al.
Publicado: (2021)

Optimising preoperative risk stratification tools for prostate cancer using mpMRI
por: Reisæter, Lars A. R., et al.
Publicado: (2017)

Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information
por: Han, Chao, et al.
Publicado: (2021)

The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions
por: Zattoni, Fabio, et al.
Publicado: (2023)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Editorial Comment: Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Diniz, Andre Luiz Lima
Publicado: (2020)

AI-predicted mpMRI image features for the prediction of clinically significant prostate cancer
por: Li, Song, et al.
Publicado: (2023)

TRUS-MR Fusion Biopsy of the Prostate: Radiological and Histological Correlation
por: Lavaerts, Michel, et al.
Publicado: (2016)

mpMRI-US Fusion-Guided Targeted Cryotherapy in Patients with Primary Localized Prostate Cancer: A Prospective Analysis of Oncological and Functional Outcomes
por: Fernández-Pascual, Esaú, et al.
Publicado: (2022)

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Carbunaru, Samuel, et al.
Publicado: (2021)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

Focal Irreversible Electroporation for Localized Prostate Cancer – Oncological and Safety Outcomes Using mpMRI and Transperineal Biopsy Follow-Up
por: Gielchinsky, Ilan, et al.
Publicado: (2023)

Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores
por: Tomioka, Masayuki, et al.
Publicado: (2023)

Developing a predictive model for clinically significant prostate cancer by combining age, PSA density, and mpMRI
por: Ma, Zengni, et al.
Publicado: (2023)

Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate—Unnecessary or Underutilised? A Narrative Review
por: Guljaš, Silva, et al.
Publicado: (2023)

Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors
por: Häggman, Michael, et al.
Publicado: (2022)

A Nomogram Based on a TRUS Five-Grade Scoring System for the Prediction of Prostate Cancer and High Grade Prostate Cancer at Initial TRUS-Guided Biopsy
por: Xie, Shao Wei, et al.
Publicado: (2018)

Intraoperative 3D-US-mpMRI Elastic Fusion Imaging-Guided Robotic Radical Prostatectomy: A Pilot Study
por: Oderda, Marco, et al.
Publicado: (2022)

Patients’ experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study
por: Pizzoli, Silvia Francesca Maria, et al.
Publicado: (2020)

Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy
por: Huang, Haifeng, et al.
Publicado: (2016)

Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study
por: Rakauskas, Arnas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5npfv27h9p3h5i32lkiuddegiv